SynthesisCurrent neuropharmacology2023

Nabiximols is Efficient as Add-On Treatment for Patients with Multiple Sclerosis Spasticity Refractory to Standard Treatment: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.

Dénes Kleiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.